Investing.com - Corbus Pharmaceuticals (NASDAQ:CRBP) Holding reported on Tuesday third quarter earnings that missed analysts' forecasts and revenue that fell short of expectations.
Corbus Pharmaceuticals Holding announced earnings per share of $-0.0700 on revenue of $0.00. Analysts polled by Investing.com anticipated EPS of $-0.0600 on revenue of $220K.
Corbus Pharmaceuticals Holding shares are down 41.36% from the beginning of the year, still down 88.51% from its 52 week high of $1.11 set on November 16, 2021.
Corbus Pharmaceuticals Holding shares lost 1.92% in intra-day trade following the report.
Corbus Pharmaceuticals Holding follows other major Healthcare sector earnings this month
Corbus Pharmaceuticals Holding's report follows an earnings beat by UnitedHealth on October 14, who reported EPS of $5.79 on revenue of $80.89B, compared to forecasts EPS of $5.43 on revenue of $80.52B.
J&J had beat expectations on October 18 with third quarter EPS of $2.55 on revenue of $23.79B, compared to forecast for EPS of $2.52 on revenue of $23.46B.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar